# Pioglitazone

## Actos 30mg

| 藥物代碼           | OACT3                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Monotherapy or in combination with sulphonylureas, metformin or insulin in patients with type II diabetes.                                                                                                                                                                                                                                                      |
| 副作用             | Edema, upper respiratory tract infection, headache, myalgia.Cardiovascular: Edema (4.8% to 15.3% )Endocrine metabolic: Weight gainHematologic: Anemia (less than or equal to 2% )Musculoskeletal: Fracture of bone (5.1% ), Myalgia (5.4%)Neurologic: Headache (9.1% )Respiratory: Pharyngitis (5.1% ), Sinusitis (6.3% ), Upper respiratory infection (13.2% ) |
| 禁忌               | Type 1 diabetes, diabetic ketoacidosis. Active hepatic disease or ALT levels > 2.5 times the upper limit of normal. NYHA class III or IV heart failure.                                                                                                                                                                                                         |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量           | Initiate at 15 or 30 mg once daily. Max 45 mg once daily.                                                                                                                                                                                                                                                                                                       |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest moderate risk                                                                                                                                                                                                                                                                                                     |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                             |

